Callodine Acquisition Corporation (CALQ)

Callodine Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price

Company Description

Callodine Acquisition is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

While we will look at a diverse variety of investment strategies and business models within the investment management industry, we intend to focus on potential targets within the private alternative asset manager universe that pursue investment strategies offering strong cash yields.

This is consistent with the core competency of both Callodine and our management team. James Morrow is the Chief Executive Officer (“CEO”) and founder of Callodine.

Prior to founding Callodine, Mr. Morrow spent the previous 19 years at Fidelity Investments, where, at peak, he managed $40 billion of assets across multiple equity-income strategies, including upwards of $1 billion invested in alternative asset managers.

Callodine Acquisition Corporation
Country United States
Founded 2021
Industry Blank Check / SPAC
CEO James S. Morrow

Contact Details

Two International Place, Suite 1830
Boston, MA 02110
United States
Phone (617) 880-7480

Stock Details

Ticker Symbol CALQ
Exchange NASDAQ
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1843080

Key Executives

Name Position
James S. Morrow Chairman of the Board and Chief Executive Officer
Marc Irizarry President
Austin McClintock Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer and Director
Tyler Bak Head of Business Development

Latest SEC Filings

Date Type Title
May 5, 2022 SEC STAFF ACTION SEC Staff Action: ORDER
Mar 19, 2021 8-A12B Registration of securities [Section 12(b)]
Mar 16, 2021 S-1/A General form for registration of securities under the Securities Act of 1933
Mar 5, 2021 S-1 General form for registration of securities under the Securities Act of 1933
Feb 5, 2021 DRS Draft Registration Statement